Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 4
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J, Nykter M, Czerniak BA, Brown PH, Swanton C, Msaouel P, Maitra A, Kopetz S, Campbell P, Speed TP, Boutros PC, Zhu H, Urbanucci A, Demeulemeester J, Van Loo P, Wang W. Cao S, et al. Among authors: spetsieris n. Nat Biotechnol. 2022 Nov;40(11):1624-1633. doi: 10.1038/s41587-022-01342-x. Epub 2022 Jun 13. Nat Biotechnol. 2022. PMID: 35697807 Free PMC article.
Neuroendocrine and Aggressive-Variant Prostate Cancer.
Spetsieris N, Boukovala M, Patsakis G, Alafis I, Efstathiou E. Spetsieris N, et al. Cancers (Basel). 2020 Dec 16;12(12):3792. doi: 10.3390/cancers12123792. Cancers (Basel). 2020. PMID: 33339136 Free PMC article. Review.
An evaluation of apalutamide for the treatment of prostate cancer.
Boukovala M, Spetsieris N, Efstathiou E. Boukovala M, et al. Among authors: spetsieris n. Expert Opin Pharmacother. 2020 Sep;21(13):1537-1546. doi: 10.1080/14656566.2020.1770726. Epub 2020 Jun 16. Expert Opin Pharmacother. 2020. PMID: 32543237 Review.
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.
Spetsieris N, Boukovala M, Alafis I, Davis J, Zurita A, Wang X, Tu SM, Chapin BF, Aparicio A, Corn P, Wang J, Subudhi SK, Araujo J, Papadopoulos J, Pruitt L, Weldon JA, Logothetis CJ, Efstathiou E. Spetsieris N, et al. Eur J Cancer. 2021 Nov;157:259-267. doi: 10.1016/j.ejca.2021.06.017. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536949 Clinical Trial.
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer.
Spetsieris N, Boukovala M, Weldon JA, Tsikkinis A, Hoang A, Aparicio A, Tu SM, Araujo JC, Zurita AJ, Corn PG, Pagliaro L, Kim J, Wang J, Subudhi SK, Tannir NM, Logothetis CJ, Troncoso P, Wang X, Wen S, Efstathiou E. Spetsieris N, et al. Clin Genitourin Cancer. 2021 Feb;19(1):22-31.e5. doi: 10.1016/j.clgc.2020.05.013. Epub 2020 May 30. Clin Genitourin Cancer. 2021. PMID: 32675015 Free PMC article. Clinical Trial.
A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer.
Boukovala M, Spetsieris N, Weldon JA, Tsikkinis A, Hoang A, Aparicio A, Tu SM, Araujo JC, Zurita AJ, Corn PG, Pagliaro L, Kim J, Wang J, Subudhi SK, Tannir NM, Logothetis CJ, Troncoso P, Wen S, Efstathiou E. Boukovala M, et al. Among authors: spetsieris n. Eur J Cancer. 2020 Mar;127:67-75. doi: 10.1016/j.ejca.2019.12.027. Epub 2020 Jan 24. Eur J Cancer. 2020. PMID: 31986451 Free PMC article. Clinical Trial.